Cell type specificity and host genetic polymorphisms influence antibody-dependent enhancement of dengue virus infection

Journal of Virology

Volumn 85, Issue 4, 2011, Pages 1671-1683

  Boonnak, Kobporn ^a   Dambach, Kaitlyn M ^a   Donofrio, Gina C ^a   Tassaneetrithep, Boonrat ^a,c   Marovich, Mary A ^a,b,d  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY DEPENDENT ENHANCEMENT; APHERESIS; ARTICLE; CELL MATURATION; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DENGUE; DENGUE VIRUS; GENETIC POLYMORPHISM; HAPLOTYPE; HOST; HUMAN; HUMAN CELL; INFECTION RATE; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD;

ANTIBODIES, VIRAL; ANTIBODY-DEPENDENT ENHANCEMENT; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DENGUE; DENGUE VIRUS; HUMANS; INTERLEUKIN-10; MACROPHAGES; MONOCYTES; PHAGOCYTES; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; VIRUS REPLICATION;

DENGUE VIRUS;

EID: 78951488927     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00220-10     Document Type: Article

References (59)

1. Boonnak, K., et al. 2008. Role of dendritic cells in antibody-dependent enhancement of dengue virus infection. J. Virol. 82:3939-3951.
2. Brown, M. G., et al. 2009. Dramatic caspase-dependent apoptosis in antibody- enhanced dengue virus infection of human mast cells. J. Leukoc. Biol. 85:71-80.
3. Chareonsirisuthigul, T., S. Kalayanarooj, and S. Ubol. 2007. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. J. Gen. Virol. 88:365-375.
4. Chaturvedi, U. C., R. Agarwal, E. A. Elbishbishi, and A. S. Mustafa. 2000. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. FEMS Immunol. Med. Microbiol. 28:183-188.
5. Chen, L. C., et al. 2006. Correlation of serum levels of macrophage migration inhibitory factor with disease severity and clinical outcome in dengue patients. Am. J. Trop. Med. Hyg. 74:142-147.
6. Dejnirattisai, W., et al. 2010. Cross-reacting antibodies enhance dengue virus infection in humans. Science 328:745-748.
7. De Smedt, T., et al. 1997. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27:1229-1235.
8. Diamond, M. S., and E. Harris. 2001. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology 289:297-311.
9. Durbin, A. P., et al. 2008. Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever. Virology 376:429-435.
10. Eckels, K. H., W. E. Brandt, V. R. Harrison, J. M. McCown, and P. K. Russell. 1976. Isolation of a temperature-sensitive dengue-2 virus under conditions suitable for vaccine development. Infect. Immun. 14:1221-1227.
11. Fink, J., F. Gu, and S. G. Vasudevan. 2006. Role of T cells, cytokines and antibody in dengue fever and dengue haemorrhagic fever. Rev. Med. Virol. 16:263-275.
12. Gerber, J. S., and D. M. Mosser. 2001. Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. J. Immunol. 166:6861-6868.
13. Grazia Cappiello, M., F. S. Sutterwala, G. Trinchieri, D. M. Mosser, and X. Ma. 2001. Suppression of Il-12 transcription in macrophages following Fc gamma receptor ligation. J. Immunol. 166:4498-4506.
14. Green, S., et al. 1999. Elevated plasma interleukin-10 levels in acute dengue correlate with disease severity. J. Med. Virol. 59:329-334.
15. Halstead, S. B. 2003. Neutralization and antibody-dependent enhancement of dengue viruses. Adv. Virus Res. 60:421-467.
16. Halstead, S. B., et al. 1983. Comparison of P388D1 mouse macrophage cell line and human monocytes for assay of dengue-2 infection-enhancing antibodies. Am. J. Trop. Med. Hyg. 32:157-163.
17. Halstead, S. B., and E. J. O'Rourke. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146:201-217.
18. Ho, L. J., et al. 2005. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J. Immunol. 174:8163-8172.
19. Huisman, W., B. E. Martina, G. F. Rimmelzwaan, R. A. Gruters, and A. D. Osterhaus. 2009. Vaccine-induced enhancement of viral infections. Vaccine 27:505-512.
20. Jindadamrongwech, S., C. Thepparit, and D. R. Smith. 2004. Identification of GRP 78 (BiP) as a liver cell expressed receptor element for dengue virus serotype 2. Arch. Virol. 149:915-927.
21. Johnson, A. J., and J. T. Roehrig. 1999. New mouse model for dengue virus vaccine testing. J. Virol. 73:783-786.
22. Kliks, S. C., A. Nisalak, W. E. Brandt, L. Wahl, and D. S. Burke. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40:444-451.
23. Knapp, S., et al. 2003. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 55:362-369.
24. Kou, Z., et al. 2008. Monocytes, but not T or B cells, are the principal target cells for dengue virus (DV) infection among human peripheral blood mononuclear cells. J. Med. Virol. 80:134-146.
25. Lidbury, B. A., and S. Mahalingam. 2000. Specific ablation of antiviral gene expression in macrophages by antibody-dependent enhancement of Ross River virus infection. J. Virol. 74:8376-8381.
26. Littaua, R., I. Kurane, and F. A. Ennis. 1990. Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J. Immunol. 144:3183-3186.
27. Lopatin, U., et al. 2001. Increases in circulating and lymphoid tissue interleukin- 10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood 97:3161-3170.
28. Mady, B. J., D. V. Erbe, I. Kurane, M. W. Fanger, and F. A. Ennis. 1991. Antibody-dependent enhancement of dengue virus infection mediated by bispecific antibodies against cell surface molecules other than Fc gamma receptors. J. Immunol. 147:3139-3144.
29. Mahalingam, S., and B. A. Lidbury. 2002. Suppression of lipopolysaccharide- induced antiviral transcription factor (STAT-1 and NF-kappa B) complexes by antibody-dependent enhancement of macrophage infection by Ross River virus. Proc. Natl. Acad. Sci. U. S. A. 99:13819-13824.
30. Marovich, M., et al. 2001. Human dendritic cells as targets of dengue virus infection. J. Invest. Dermatol. Symp. Proc. 6:219-224.
31. Marovich, M. A., et al. 2002. Preparation of clinical-grade recombinant canarypox-human immunodeficiency virus vaccine-loaded human dendritic cells. J. Infect. Dis. 186:1242-1252.
32. Meenagh, A., et al. 2002. Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America. Hum. Immunol. 63:1055-1061.
33. Mege, J. L., S. Meghari, A. Honstettre, C. Capo, and D. Raoult. 2006. The two faces of interleukin 10 in human infectious diseases. Lancet Infect. Dis. 6:557-569.
34. Miller, J. L., et al. 2008. The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog. 4:e17.
35. Miyazoe, S., et al. 2002. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am. J. Gastroenterol. 97:2086-2092.
36. Moi, M. L., C. K. Lim, T. Takasaki, and I. Kurane. 2010. Involvement of the Fc gamma receptor IIA cytoplasmic domain in antibody-dependent enhancement of dengue virus infection. J. Gen. Virol. 91:103-111.
37. Morens, D. M., and A. S. Fauci. 2008. Dengue and hemorrhagic fever: a potential threat to public health in the United States. JAMA 299:214-216.
38. Muller, G., et al. 2002. Interleukin-10-treated dendritic cells modulate immune responses of naive and sensitized T cells in vivo. J. Invest. Dermatol. 119:836-841.
39. Navarro-Sanchez, E., et al. 2003. Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep. 4:723-728.
40. Nguyen, T. H., et al. 2004. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J. Infect. Dis. 189:221-232.
41. Opdal, S. H. 2004. IL-10 gene polymorphisms in infectious disease and SIDS. FEMS Immunol. Med. Microbiol. 42:48-52.
42. Palmer, D. R., et al. 2005. Differential effects of dengue virus on infected and bystander dendritic cells. J. Virol. 79:2432-2439.
43. Perez, A. B., et al. 2004. IL-10 levels in Dengue patients: some findings from the exceptional epidemiological conditions in Cuba. J. Med. Virol. 73:230-234.
44. Redpath, S., P. Ghazal, and N. R. Gascoigne. 2001. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol. 9:86-92.
45. Shin, H. D., et al. 2000. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc. Natl. Acad. Sci. U. S. A. 97:14467-14472.
46. Shresta, S., et al. 2004. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-celldependent immunity are less critical. J. Virol. 78:2701-2710.
47. Smith, A. J., and S. E. Humphries. 2009. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev. 20:43-59.
48. Stark, G. R., I. M. Kerr, B. R. Williams, R. H. Silverman, and R. D. Schreiber. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67:227-264.
49. Steinbrink, K., M. Wolfl, H. Jonuleit, J. Knop, and A. H. Enk. 1997. Induction of tolerance by IL-10-treated dendritic cells. J. Immunol. 159:4772-4780.
50. Stetson, D. B., and R. Medzhitov. 2006. Antiviral defense: interferons and beyond. J. Exp. Med. 203:1837-1841.
51. Stetson, D. B., and R. Medzhitov. 2006. Type I interferons in host defense. Immunity 25:373-381.
52. Suksanpaisan, L., A. Cabrera-Hernandez, and D. R. Smith. 2007. Infection of human primary hepatocytes with dengue virus serotype 2. J. Med. Virol. 79:300-307.
53. Sutterwala, F. S., G. J. Noel, R. Clynes, and D. M. Mosser. 1997. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J. Exp. Med. 185:1977-1985.
54. Sutterwala, F. S., G. J. Noel, P. Salgame, and D. M. Mosser. 1998. Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J. Exp. Med. 188:217-222.
55. Tassaneetrithep, B., et al. 2003. DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 197:823-829.
56. Turner, D. M., et al. 1997. An investigation of polymorphism in the interleukin- 10 gene promoter. Eur. J. Immunogenet. 24:1-8.
57. Westendorp, R. G., J. A. Langermans, T. W. Huizinga, C. L. Verweij, and A. Sturk. 1997. Genetic influence on cytokine production in meningococcal disease. Lancet 349:1912-1913.
58. Wu, S. J., et al. 2000. Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 6:816-820.
59. Zaba, L. C., J. Fuentes-Duculan, R. M. Steinman, J. G. Krueger, and M. A. Lowes. 2007. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J. Clin. Invest. 117:2517-2525.